ZA942872B - Transdermal therapeutic systems for administering active substances - Google Patents

Transdermal therapeutic systems for administering active substances

Info

Publication number
ZA942872B
ZA942872B ZA942872A ZA942872A ZA942872B ZA 942872 B ZA942872 B ZA 942872B ZA 942872 A ZA942872 A ZA 942872A ZA 942872 A ZA942872 A ZA 942872A ZA 942872 B ZA942872 B ZA 942872B
Authority
ZA
South Africa
Prior art keywords
active substances
transdermal therapeutic
therapeutic systems
administering active
administering
Prior art date
Application number
ZA942872A
Inventor
Harald Dr List
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of ZA942872B publication Critical patent/ZA942872B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

The invention concerns a transdermal therapeutic system for the systemic administration of active substances, the system being characterized in that at least one of the active substances is a serotonin agonist selected from the indole derivatives, e.g. sumatriptan.
ZA942872A 1993-05-06 1994-04-26 Transdermal therapeutic systems for administering active substances ZA942872B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4314976A DE4314976C1 (en) 1993-05-06 1993-05-06 Transdermal therapeutic systems for the administration of drugs, process for their production and their use

Publications (1)

Publication Number Publication Date
ZA942872B true ZA942872B (en) 1995-07-06

Family

ID=6487316

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA942872A ZA942872B (en) 1993-05-06 1994-04-26 Transdermal therapeutic systems for administering active substances

Country Status (20)

Country Link
EP (1) EP0697869B1 (en)
JP (1) JPH08509749A (en)
KR (1) KR960702306A (en)
AT (1) ATE183392T1 (en)
AU (1) AU686159B2 (en)
CA (1) CA2160776A1 (en)
CZ (1) CZ289395A3 (en)
DE (2) DE4314976C1 (en)
DK (1) DK0697869T3 (en)
ES (1) ES2138659T3 (en)
FI (1) FI955260A (en)
GR (1) GR3031639T3 (en)
HU (1) HUT74865A (en)
IL (1) IL109509A (en)
NO (1) NO954414D0 (en)
NZ (1) NZ265949A (en)
PL (1) PL179353B1 (en)
SK (1) SK138095A3 (en)
WO (1) WO1994026270A1 (en)
ZA (1) ZA942872B (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9509985A (en) 1995-12-12 1998-11-03 Omeros Med Sys Inc Solution for irrigation and method for inhibiting pain, inflammation and sparse
US8022095B2 (en) 1996-08-16 2011-09-20 Pozen, Inc. Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs
WO2001043736A1 (en) * 1999-12-14 2001-06-21 Teikoku Seiyaku Co., Ltd. Drugs for relieving hemicrania
US20030013753A1 (en) * 2001-06-05 2003-01-16 Ronald Aung-Din Transdermal migraine therapy
US8329734B2 (en) 2009-07-27 2012-12-11 Afgin Pharma Llc Topical therapy for migraine
PT1575566E (en) 2002-12-26 2012-03-29 Pozen Inc Multilayer dosage forms containing naproxen and triptans
WO2004112723A2 (en) 2003-06-20 2004-12-29 Ronald Aung-Din Tropical therapy for the treatment of migraines, muscle sprains, muscle spasm, spasticity and related conditions
JP5225100B2 (en) 2005-12-20 2013-07-03 テイコク ファーマ ユーエスエー インコーポレーテッド Method for transdermal administration of indole serotonin receptor agonist and transdermal composition for using the same
CN101472644B (en) * 2006-04-13 2014-04-23 纽帕特公司 Transdermal methods and systems for the delivery of anti-migraine compounds
AU2009269129B2 (en) 2008-06-30 2015-08-20 Afgin Pharma, Llc Topical regional neuro-affective therapy
CA2775404C (en) 2009-09-25 2017-01-03 Dr. Reddy's Laboratories Limited Formulations comprising triptan compounds
US11337962B2 (en) 2009-09-25 2022-05-24 Upsher-Smith Laboratories, Llc Formulations comprising triptan compounds
JP6216151B2 (en) * 2013-04-19 2017-10-18 コスメディ製薬株式会社 Hydrophilic drug emulsion patch
US10716766B2 (en) 2015-03-02 2020-07-21 Afgin Pharma, Llc Topical regional neuro-affective therapy with cannabinoids
US10383816B2 (en) 2015-03-02 2019-08-20 Afgin Pharma, Llc Topical regional neuro-affective therapy with cannabinoid combination products
US20180049994A1 (en) 2016-08-16 2018-02-22 Afgin Pharma, Llc Topical regional neuro-affective therapy with caryophyllene

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3996934A (en) * 1971-08-09 1976-12-14 Alza Corporation Medical bandage
US3742951A (en) * 1971-08-09 1973-07-03 Alza Corp Bandage for controlled release of vasodilators
US5288498A (en) * 1985-05-01 1994-02-22 University Of Utah Research Foundation Compositions of oral nondissolvable matrixes for transmucosal administration of medicaments
GB2162522B (en) * 1984-08-01 1988-02-24 Glaxo Group Ltd An indole derivative
WO1992000103A1 (en) * 1990-06-28 1992-01-09 Beecham Group Plc Pharmaceutical preparations
GB9103770D0 (en) * 1991-02-22 1991-04-10 Glaxo Group Ltd Chemical compounds
GB9104890D0 (en) * 1991-03-08 1991-04-24 Glaxo Group Ltd Compositions

Also Published As

Publication number Publication date
ES2138659T3 (en) 2000-01-16
NZ265949A (en) 1997-10-24
CA2160776A1 (en) 1994-11-24
WO1994026270A1 (en) 1994-11-24
NO954414L (en) 1995-11-03
AU686159B2 (en) 1998-02-05
GR3031639T3 (en) 2000-02-29
ATE183392T1 (en) 1999-09-15
PL179353B1 (en) 2000-08-31
IL109509A0 (en) 1994-08-26
KR960702306A (en) 1996-04-27
HUT74865A (en) 1997-02-28
DE59408643D1 (en) 1999-09-23
HU9503167D0 (en) 1996-01-29
AU6648094A (en) 1994-12-12
SK138095A3 (en) 1996-06-05
NO954414D0 (en) 1995-11-03
EP0697869A1 (en) 1996-02-28
DK0697869T3 (en) 2000-03-20
JPH08509749A (en) 1996-10-15
EP0697869B1 (en) 1999-08-18
PL311591A1 (en) 1996-02-19
FI955260A0 (en) 1995-11-02
FI955260A (en) 1995-11-17
DE4314976C1 (en) 1994-10-06
IL109509A (en) 1999-12-22
CZ289395A3 (en) 1996-04-17

Similar Documents

Publication Publication Date Title
ZA942872B (en) Transdermal therapeutic systems for administering active substances
DE69527509D1 (en) HYDROGEL FORMULATION WITH CONTROLLED RELEASE
MX9706449A (en) Pharmaceutical composition for piperidinoalkanol compounds.
FI930862A0 (en) EN DOSERINGSFORM FOER TIDSVARIERANDE MOENSTER AV LAEKEMEDELOEVERLAOTELSE
MA26456A1 (en) PHARMACEUTICAL FORMULATIONS FOR THE EXTENDED DELIVERY OF MEDICAMENT.
AU4449789A (en) Delivery system for pharmaceutical or therapeutic actives
HK1016886A1 (en) Drug delivery system for two or more active substances
ZA928011B (en) Transdermal administration of melatonin.
AU6675198A (en) Transdermal drug delivery system for the administration of tamsulosin, and related compositions and methods of use
PL331709A1 (en) Cytotoxic aminosaccharic and affinite saccharic derivatives of indolopyrrole carbazoles
WO1997037640A3 (en) Uniform drug delivery therapy
BR9608255A (en) Transdermal therapeutic system (stt) for testosterone administration
ZA968905B (en) Transdermal therapeutic system (tts) for administering active substances for drug dependence or drug addiction
GEP20043157B (en) Medicament Against Migraine Recurrence
PL348202A1 (en) Pharmaceutically active composition and dispensing device
MX9709453A (en) Oral pharmaceutical composition of piperidinoalkanol compounds in solution form.
ZA963744B (en) Topical aciclovir preparation
IL96506A0 (en) Transdermal system for administering pharmaceutical compounds under ph control
SI0697869T1 (en) Transdermal therapeutic systems for the administration of serotonin agonists
ZA966083B (en) Agent for transdermal administration containing esters of 13-ethyl-17ß-hydroxy-11-methylene-18,19-dinor-17Ó-pregn-4-en-20-yn-3-one.
MX9605190A (en) Effective dosage form for antiepileptic drugs.
MX9705324A (en) Transdermal therapeutic system for dispensing (s)-3-methyl-5-(1-methyl-2-pyrrolidenyl)-isoxazole or one of its pharmaceutically acceptable salts.